Cargando…

SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1

MicroRNA (miRNA) can function as tumor suppressors or oncogenes, and also as potential specific cancer biomarkers; however, there are few published studies on miRNA in synovial sarcomas, and their function remains unclear. We transfected the OncomiR miRNA Precursor Virus Library into synovial sarcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minami, Yusuke, Kohsaka, Shinji, Tsuda, Masumi, Yachi, Kazuhiro, Hatori, Nobuaki, Tanino, Mishie, Kimura, Taichi, Nishihara, Hiroshi, Minami, Akio, Iwasaki, Norimasa, Tanaka, Shinya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462386/ https://www.ncbi.nlm.nih.gov/pubmed/24989082 http://dx.doi.org/10.1111/cas.12479

Ejemplares similares

Proteomic signatures corresponding to the SS18/SSX fusion gene in synovial sarcoma
por: Ishii, Midori, et al.
Publicado: (2018)

SS18-SSX drives CREB activation in synovial sarcoma
por: Cyra, Magdalene, et al.
Publicado: (2022)

The clinical implication of SS18-SSX fusion gene in synovial sarcoma
por: Ren, T, et al.
Publicado: (2013)

Truncated SSX Protein Suppresses Synovial Sarcoma Cell Proliferation by Inhibiting the Localization of SS18-SSX Fusion Protein
por: Yoneda, Yasushi, et al.
Publicado: (2013)

Expanding the Use of an SS18-SSX Antibody for Molecular Assays in Synovial Sarcoma
por: Raquib, Ainiah Rushdiana, et al.
Publicado: (2022)

Usefulness of SS18-SSX antibody as a diagnostic marker for pulmonary metastatic synovial sarcoma
por: Miura, Kentaro, et al.
Publicado: (2021)

Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases
por: Przybyl, Joanna, et al.
Publicado: (2012)

Prognostic value of SS18–SSX fusion type in synovial sarcoma; systematic review and meta-analysis
por: Kubo, Tadahiko, et al.
Publicado: (2015)

Cooperation between SS18-SSX1 and miR-214 in Synovial Sarcoma Development and Progression
por: Tanaka, Miwa, et al.
Publicado: (2020)

Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas
por: Cheng, Yanli, et al.
Publicado: (2022)

Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells
por: Matsumoto, Ryuji, et al.
Publicado: (2016)

A Clinicopathological Analysis of Six Autopsy Cases of Sudden Unexpected Death due to Infectious Aortitis in Patients with Aortic Tears
por: Ishikawa, Marin, et al.
Publicado: (2018)

SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier
por: Tamaki, Sakura, et al.
Publicado: (2015)

Detection of SS18-SSX1/2 fusion transcripts in circulating tumor cells of patients with synovial sarcoma
por: Przybyl, Joanna, et al.
Publicado: (2019)

A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18–SSX Induces Canonical BAF Destruction
por: Li, Jinxiu, et al.
Publicado: (2021)

Protective roles of cytoplasmic p21(Cip1) (/Waf1) in senolysis and ferroptosis of lung cancer cells
por: Koyanagi, Akira, et al.
Publicado: (2022)

β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition
por: Barrott, Jared J., et al.
Publicado: (2015)

Novel signaling collaboration between TGF-β and adaptor protein Crk facilitates EMT in human lung cancer
por: Elmansuri, Aiman Z., et al.
Publicado: (2016)

SYT-SSX fusion genes and prognosis in synovial sarcoma
por: Mezzelani, A, et al.
Publicado: (2001)

Adaptor protein CRK induces epithelial–mesenchymal transition and metastasis of bladder cancer cells through HGF/c-Met feedback loop
por: Matsumoto, Ryuji, et al.
Publicado: (2015)

MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction
por: Di Mauro, Ilaria, et al.
Publicado: (2020)

Expression of p21(waf‐1/cip‐1) Is Significantly Induced in the Livers of LEC Rats with Chronic Liver Injury
por: Sawada, Norimasa, et al.
Publicado: (1996)

Epigenetic Regulation of p21(cip1/waf1) in Human Cancer
por: Ocker, Matthias, et al.
Publicado: (2019)

Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma
por: Peng, Changliang, et al.
Publicado: (2016)

Primary monophasic synovial sarcoma of the cervical esophagus confirmed by detection of the SS18-SSX2 fusion transcripts: case report and literature review
por: Sasaki, Ken, et al.
Publicado: (2020)

Protective role of cytoplasmic p21Cip1/Waf1 in apoptosis of CDK4/6 inhibitor‐induced senescence in breast cancer cells
por: Kartika, Irna D., et al.
Publicado: (2021)

The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma
por: Cironi, Luisa, et al.
Publicado: (2016)

Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours.
por: Koopmann, J., et al.
Publicado: (1995)

Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.
por: Ito, Y., et al.
Publicado: (1996)

Regenerative Response in Ischemic Brain Restricted by p21(cip1/waf1)
por: Qiu, Jianhua, et al.
Publicado: (2004)

p21(WAF1/CIP1) Expression is Differentially Regulated by Metformin and Rapamycin
por: Molnar, Zoltan, et al.
Publicado: (2014)

Cell Cycle‐dependent Modulation of Promoter Activities of RB and WAF1/Cip1 Genes
por: Matsumoto, Takuji, et al.
Publicado: (1998)

TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response
por: Pisonero-Vaquero, Sandra, et al.
Publicado: (2020)

miR-23a promotes invasion of glioblastoma via HOXD10-regulated glial-mesenchymal transition
por: Yachi, Kazuhiro, et al.
Publicado: (2018)

The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review).
por: Pérez-Sayáns, Mario, et al.
Publicado: (2013)

Prognostic Implication of Histological Oligodendroglial Tumor Component: Clinicopathological Analysis of 111 Cases of Malignant Gliomas
por: Kanno, Hiromi, et al.
Publicado: (2012)

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma
por: Kawaguchi, Satoshi, et al.
Publicado: (2005)

WAF1/CIP1 structural abnormalities do not contribute to cell cycle deregulation in ovarian cancer.
por: Wan, M., et al.
Publicado: (1996)

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma.
por: Ogawa, M., et al.
Publicado: (1997)

TRIM3, a tumor suppressor linked to regulation of p21(Waf1/Cip1)
por: Liu, Yuhui, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qrl4soot231nfefvlvm4sb3jph